MARGetuximab Or Trastuzumab (MARGOT)

NCT04425018 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
HER2-positive Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Pertuzumab
DRUG: Margetuximab
DRUG: Trastuzumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]